Pharmaceutical Industry Information Portal

HomeTagsAlladapt Immunotherapeutics

All posts by tag

Alladapt Immunotherapeutics

Alladapt announces $119M institutional financing to support ongoing clinical development

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the closing of a $119 million...
spot_img

Expert Articles

spot_img